ARCHIVES

Review Of NCI Intramural Program Offers Over 60 Recommendations For Change

This article is from The Cancer Letter archive.

Vol. 21 No. 27 | July 7, 1995

Download PDF Visit The Full Archive

Related Articles

FDA Advisors Uphold Broad Mandate To Limit Use Of ESA Products In Cancer Indications.

May 11, 2007

Release of Mayo Pathology Report Would Be Needed To Confirm Stage IIA Diagnosis.

October 24, 2008

DCT Board Approves Concept For BRMP Master Agreement

June 26, 1987

NCI Funded Over 4,500 Grants Last Year, Half Its $3B Budget.

January 19, 2001

The March: Cancer Centers To Plan Events In Conjunction With Sept. 26 March

April 10, 1998

ORI Finds St. Mary’s Data Managers Falsified Data In BCPT

September 8, 1995